Results 71 to 80 of about 23,896 (206)

Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps [PDF]

, 2020
Rory Chan, Chris RuiWen Kuo, Brian J. Lipworth   +2 more
openalex   +1 more source

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

Drug Design, Development and Therapy, 2017
Corrado Pelaia,1 Alessandro Vatrella,2 Maria Teresa Busceti,1 Luca Gallelli,3 Rosa Terracciano,3 Rocco Savino,3 Girolamo Pelaia1 1Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University “Magna Græcia&rdquo ...
Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G   +6 more
doaj  

Long-Term Safety and Efficacy of Mepolizumab in Patients with Severe Eosinophilic Asthma [PDF]

, 2016
Frank C. Albers, Njira Lugogo, M Gilson, Robert G. Price, Steven W. Yancey   +4 more
openalex   +1 more source

TNF Superfamily and ILC2 Activation in Asthma

Biomolecules
Eosinophilic asthma is the most prevalent and well-defined phenotype of asthma. Despite a majority of patients responding to corticosteroid therapy and T2 biologics, there remains a subset that have recurrent asthma exacerbations, highlighting a need for
Takahiro Matsuyama, Brittany Marie Salter, Nahal Emami Fard, Kentaro Machida, Roma Sehmi   +4 more
doaj   +1 more source

Novel treatment of severe eosinophilic asthma

Педиатрическая фармакология, 2020
/
openaire   +1 more source

Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthma [PDF]

, 2023
Nora Drick, Lina Brinkmann, Jan Fuge, Tobias Welte, Hendrik Suhling   +4 more
openalex   +1 more source

Short-term pulmonary infiltrate with eosinophilia caused by asthma: a phenotype of severe, eosinophilic asthma? Five cases and a review of the literature [PDF]

, 2019
Min Sup Song, Shan Cai, Hong Luo, Yi Jiang, Min Yang, Yan Zhang, Hong Peng, Ping Chen   +7 more
openalex   +1 more source

Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities [PDF]

, 2020
Claudia Crimi, Raffaele Campisi, Giulia Cacopardo, Rossella Intravaia, Santi Nolasco, Morena Porto, Corrado Pelaia, Nunzio Crimi   +7 more
openalex   +1 more source

Additional file 2 of Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study

, 2020
Takanori Numata, Hanae Miyagawa, Saiko Nishioka, Keitaro Okuda, Hirofumi Utsumi, Mitsuo Hashimoto, Shunsuke Minagawa, Takeo Ishikawa, Hiromichi Hara, Jun Araya, Kazuyoshi Kuwano   +10 more
openalex   +1 more source

Anti-IL-5 therapy in patients with severe eosinophilic asthma – clinical efficacy and possible criteria for treatment response [PDF]

, 2018
Nora Drick, Benjamin Seeliger, Tobias Welte, Jan Fuge, Hendrik Suhling   +4 more
openalex   +1 more source